Mersana Therapeutics, Inc. MRSN
29.08 USD 0.00 (+0.00%)
At closeJan 6, 2026, 4:00 PM EST
29.36 +0.28 +0.96%
After hours · Jan 6, 4:00 PM ET
28.78 Day range 29.08
52-week range unavailable
- YTD
- +0.52%
- 1 year
- -14.47%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 40.50M | 36.85M | 26.58M | 43.00K | 828.00K | |
| 40.50M | 36.85M | 26.58M | 43.00K | 828.00K | |
| -73.34M | -179.67M | -203.77M | -168.86M | -88.11M | |
| -69.19M | -171.67M | -204.21M | -170.06M | -88.05M | |
| -14.00 | -37.00 | -54.00 | -60.00 | -35.80 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 107.75M | 174.56M | 128.88M | 177.95M | 255.09M | |
| 144.66M | 226.06M | 334.34M | 206.11M | 273.40M | |
| 154.17M | 189.16M | 242.28M | 84.37M | 45.31M | |
| 28.60M | 33.63M | 36.30M | 38.18M | 16.57M | |
| -9.51M | 36.90M | 92.06M | 121.74M | 228.09M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -82.34M | -168.88M | -49.36M | -139.99M | -74.70M | |
| 11.44M | 119.88M | -152.72M | -648.00K | 37.03M | |
| 4.09M | 94.67M | 153.02M | 63.65M | 230.41M | |
| -132.00K | -2.17M | -2.20M | -648.00K | -473.00K | |
| -66.81M | 45.68M | -49.06M | -76.99M | 192.74M |